Gastrointestinal side effect profile due to the use of alendronate in the treatment of osteoporosis


Creative Commons License

Aki S., Eskiyurt N., Akarirmak U. , Tuzun F., Eryavuz M., Alper S., ...More

YONSEI MEDICAL JOURNAL, vol.44, no.6, pp.961-967, 2003 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 44 Issue: 6
  • Publication Date: 2003
  • Doi Number: 10.3349/ymj.2003.44.6.961
  • Title of Journal : YONSEI MEDICAL JOURNAL
  • Page Numbers: pp.961-967

Abstract

The aim of our study was to evaluate the upper gastrointestinal (GI) tract side effect profile in 759 female patients that had taken alendronate (10 mg/day), for at least 6 months, for the treatment of osteoporosis, in relation to the safety of alendronate and the compliance of patients to its absorption rules.